Use of iv iron saccharate in haemodialysis patients not responding to oral iron and erythropoietin

被引：10

作者：

Al-Hawas, F ^{[1
]}

Abdalla, AH ^{[1
]}

Popovich, W ^{[1
]}

Mousa, DH ^{[1
]}

Al-Sulaiman, MH ^{[1
]}

Al-Khader, AA ^{[1
]}

机构：

[1] Riyadh Armed Forces Hosp, Riyadh 11159, Saudi Arabia

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 1997年 / 12卷 / 12期

关键词：

D O I：

10.1093/ndt/12.12.2801

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

引用

页码：2801 / 2802

页数：2

共 4 条

[1] REDUCTION IN RECOMBINANT-HUMAN-ERYTHROPOIETIN DOSES BY THE USE OF CHRONIC INTRAVENOUS IRON SUPPLEMENTATION [J].

FISHBANE, S ;

FREI, GL ;

MAESAKA, J .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 26 (01) :41-46

[2]

FOURTOUNAS C, 1994, NEPHROL DIAL TRANSPL, P735

[3] DIAGNOSIS OF IRON-DEFICIENCY ANEMIA IN RENAL-FAILURE PATIENTS DURING THE POST-ERYTHROPOIETIN ERA [J].

KALANTARZADEH, K ;

HOFFKEN, B ;

WUNSCH, H ;

FINK, H ;

KLEINER, M ;

LUFT, FC .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 26 (02) :292-299

[4] EVIDENCE-BASED RECOMMENDATIONS FOR THE CLINICAL USE OF RECOMBINANT-HUMAN-ERYTHROPOIETIN [J].

MUIRHEAD, N ;

BARGMAN, J ;

BURGESS, E ;

JINDAL, KK ;

LEVIN, A ;

NOLIN, L ;

PARFREY, P .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 26 (02) :S1-S24

← 1 →